Literature DB >> 15290302

Direct effects of 9-anthracene compounds on cystic fibrosis transmembrane conductance regulator gating.

Tomohiko Ai1, Silvia G Bompadre, Yoshiro Sohma, Xiaohui Wang, Min Li, Tzyh-Chang Hwang.   

Abstract

Anthracene-9-carboxylic acid (9-AC) has been reported to show both potentiation and inhibitory effects on guinea-pig cardiac cAMP-activated chloride channels via two different binding sites, and inhibition of Mg(2+)-sensitive protein phosphatases has been proposed for the mechanism of 9-AC potentiation effect. In this study, we examined the effects of 9-AC on wild-type and mutant human cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels expressed in NIH3T3 or CHO cells. 9-AC inhibits whole-cell CFTR current in a voltage-dependent manner, whereas the potentiation effect is not affected by membrane potentials. Anthracene-9-methanol, an electro-neutral 9-AC analog, fails to block CFTR, but shows a nearly identical potentiation effect, corroborating the idea that two chemically distinct sites are responsible, respectively, for potentiation and inhibitory actions of 9-AC. 9-AC also enhances the activity of deltaR-CFTR, a constitutively active CFTR mutant whose R-domain is removed. In excised inside-out patches, 9-AC increases Po by prolonging the mean burst durations and shortening the interburst durations. We therefore conclude that two different 9-AC binding sites for potentiation and inhibitory effects on CFTR channels are located outside of the R-domain. We also speculate that 9-AC potentiates CFTR activity by directly affecting CFTR gating.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290302      PMCID: PMC1201469          DOI: 10.1007/s00424-004-1317-y

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  36 in total

1.  Genistein activates CFTR Cl- channels via a tyrosine kinase- and protein phosphatase-independent mechanism.

Authors:  P J French; J Bijman; A G Bot; W E Boomaars; B J Scholte; H R de Jonge
Journal:  Am J Physiol       Date:  1997-08

2.  Genistein potentiates wild-type and delta F508-CFTR channel activity.

Authors:  T C Hwang; F Wang; I C Yang; W W Reenstra
Journal:  Am J Physiol       Date:  1997-09

3.  Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator).

Authors:  M Ramjeesingh; C Li; E Garami; L J Huan; K Galley; Y Wang; C E Bear
Journal:  Biochemistry       Date:  1999-02-02       Impact factor: 3.162

4.  Regulation of CFTR by protein phosphatase 2B and protein kinase C.

Authors:  H Fischer; B Illek; T E Machen
Journal:  Pflugers Arch       Date:  1998-07       Impact factor: 3.657

Review 5.  Molecular pharmacology of the CFTR Cl- channel.

Authors:  T C Hwang; D N Sheppard
Journal:  Trends Pharmacol Sci       Date:  1999-11       Impact factor: 14.819

6.  Protein phosphatase 2C dephosphorylates and inactivates cystic fibrosis transmembrane conductance regulator.

Authors:  S M Travis; H A Berger; M J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  Persistent activation of a swelling-activated cation current in ventricular myocytes from dogs with tachycardia-induced congestive heart failure.

Authors:  H F Clemo; B S Stambler; C M Baumgarten
Journal:  Circ Res       Date:  1998-07-27       Impact factor: 17.367

8.  Differential regulation of single CFTR channels by PP2C, PP2A, and other phosphatases.

Authors:  J Luo; M D Pato; J R Riordan; J W Hanrahan
Journal:  Am J Physiol       Date:  1998-05

Review 9.  Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis.

Authors:  D C Gadsby; A C Nairn
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

10.  Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effects.

Authors:  F Wang; S Zeltwanger; I C Yang; A C Nairn; T C Hwang
Journal:  J Gen Physiol       Date:  1998-03       Impact factor: 4.086

View more
  7 in total

1.  Anionic selectivity sequence of the Cl(-)-H+ symporter in the synaptosomal preparation from rat brain cortex.

Authors:  M L Torres; F Ortega; I Cuaranta; J González; S Sanchez-Armass
Journal:  Neurochem Res       Date:  2008-04-11       Impact factor: 3.996

2.  CFTR chloride channel as a molecular target of anthraquinone compounds in herbal laxatives.

Authors:  Hong Yang; Li-na Xu; Cheng-yan He; Xin Liu; Rou-yu Fang; Tong-hui Ma
Journal:  Acta Pharmacol Sin       Date:  2011-05-23       Impact factor: 6.150

3.  A BLUS1 kinase signal and a decrease in intercellular CO2 concentration are necessary for stomatal opening in response to blue light.

Authors:  Sakurako Hosotani; Shota Yamauchi; Haruki Kobayashi; Saashia Fuji; Shigekazu Koya; Ken-Ichiro Shimazaki; Atsushi Takemiya
Journal:  Plant Cell       Date:  2021-07-02       Impact factor: 11.277

4.  Modulation of CFTR gating by permeant ions.

Authors:  Han-I Yeh; Jiunn-Tyng Yeh; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2014-12-15       Impact factor: 4.086

5.  The chloride-channel blocker 9-anthracenecarboxylic acid reduces the nonlinear capacitance of prestin-associated charge movement.

Authors:  Csaba Harasztosi; Anthony W Gummer
Journal:  Eur J Neurosci       Date:  2016-03-16       Impact factor: 3.386

6.  Catalyst-like modulation of transition states for CFTR channel opening and closing: new stimulation strategy exploits nonequilibrium gating.

Authors:  László Csanády; Beáta Töröcsik
Journal:  J Gen Physiol       Date:  2014-01-13       Impact factor: 4.086

7.  Mechanism of allosteric activation of TMEM16A/ANO1 channels by a commonly used chloride channel blocker.

Authors:  Chau M Ta; Aiste Adomaviciene; Nils J G Rorsman; Hannah Garnett; Paolo Tammaro
Journal:  Br J Pharmacol       Date:  2016-01-18       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.